@article{Braude_P-2020_8174, title = {The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19}, author = {Braude, P. and Carter, B. and Short, R. and Vilches-Moraga, A. and Verduri, A. and Quinn, T. and Stechman, M. and Collins, J. and Bruce, E. and Einarsson, A. and Rickard, F. and Mitchell, E. and Holloway, M. and Hesford, J. and Barlow-Pay, F. and Clini, E. and Myint, P. and Moug, S. and McCarthy, K. and Hewitt, J. and Pearce, L. and Price, A.}, month = {nov}, year = {2020}, abstract = {Objective:During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality with no literature having examined length of hospital stay. The aim of this study was to determine the influence of ACEi and ARBs on COVID-19 mortality and length of hospital stay.}, volume = {31}, journal = {International Journal of Cardiovascular Heart & Vasculature}, publisher = {Elsevier}, url = {https://doi.org/10.1016/j.ijcha.2020.100660}, }